JosephRobertSherbotieMD

PubMed

• Treatment optimization of maintenance immunosuppressive agents in pediatric renal transplant recipients
  Kathleen M. Job, Jessica K. Roberts, Elena Y. Enioutina, Sílvia M. Illamola, Shaun S. Kumar, Jahidur Rashid, Robert M. Ward, Tsuyoshi Fukuda, Joseph R. Sherbotie, Cath...> ;Expert Opinion on Drug Metabolism & Toxicology. 2021 Jun 29
• 3 citations
  Low-Dose Antithymocyte Globulin Has No Disadvantages to Standard Higher Dose in Pediatric Kidney Transplant Recipients: Report From the Pediatric Nephrology Research C...
  Isa F. Ashoor, Robbie A. Beyl, Charu Gupta, Amrish Jain, Stefan G. Kiessling, Asha Moudgil, Hiren P. Patel, Joseph R. Sherbotie, Rima S. Zahr, Vikas R. Dharnidharka, W...> ;Kidney International Reports. 2021 Jan 17
• 17 citations
  Bortezomib in the treatment of antibody-mediated rejection in pediatric kidney transplant recipients: A multicenter Midwest Pediatric Nephrology Consortium study.
  Sarah J. Kizilbash, Donna J. Claes, Isa F. Ashoor, Ashton Chen, Sara Jandeska, Raed Bou Matar, Jason Misurac, Joseph R. Sherbotie, Katherine Twombley, Priya S. Verghese> ;Pediatric Transplantation. 2017 May 1
• 14 citations
  Effects of unbound mycophenolic acid on inosine monophosphate dehydrogenase inhibition in pediatric kidney transplant patients.
  Thomas A Smits, Shareen Cox, Tsuyoshi Fukuda, Joseph R. Sherbotie, Robert M. Ward, Jens Goebel, Alexander A. Vinks> ;Therapeutic Drug Monitoring. 2014 Dec 1
• 7 citations
  Pharmacokinetics of Olmesartan Medoxomil in Pediatric Patients with Hypertension
  Thomas G. Wells, Douglas L. Blowey, Janice E. Sullivan, Jeffrey L. Blumer, Joseph R. Sherbotie, SaeHeum Song, Shashank Rohatagi, Reinilde Heyrman, Daniel E. Salazar> ;Paediatric Drugs. 2012 Dec 27
• 40 citations
  UGT1A9, UGT2B7, and MRP2 genotypes can predict mycophenolic acid pharmacokinetic variability in pediatric kidney transplant recipients.
  Tsuyoshi Fukuda, Jens Goebel, Shareen Cox, Denise Maseck, Kejian Zhang, Joseph R. Sherbotie, Eileen N. Ellis, Laura P. James, Robert M. Ward, Alexander A. Vinks> ;Therapeutic Drug Monitoring. 2012 Dec 1
• 46 citations
  Inosine Monophosphate Dehydrogenase (IMPDH) Activity as a Pharmacodynamic Biomarker of Mycophenolic Acid Effects in Pediatric Kidney Transplant Recipients
  Tsuyoshi Fukuda, Jens Goebel, Håvard Thøgersen, Denise Maseck, Shareen Cox, Barbara Logan, Joseph R. Sherbotie, Mouin G. Seikaly, Alexander A. Vinks> ;Journal of Clinical Pharmacology. 2011 Mar 1
• 2 citations
  Continuous renal replacement therapy for systemic inflammatory response syndrome: Not today*
  Donald D. Vernon, Joseph R. Sherbotie> ;Pediatric Critical Care Medicine. 2010 Nov 1
• 43 citations
  Pharmacokinetics of oral valganciclovir solution and intravenous ganciclovir in pediatric renal and liver transplant recipients.
  Mark D. Pescovitz, Robert B. Ettenger, C.F. Strife, Joseph R. Sherbotie, Susan E. Thomas, S. McDiarmid, Sharon M. Bartosh, J. Ives, M.R. Bouw, J. Bucuvalas> ;Transplant Infectious Disease. 2009 Dec 7
• 31 citations
  UGT Genotype May Contribute to Adverse Events Following Medication With Mycophenolate Mofetil in Pediatric Kidney Transplant Recipients
  SE Prausa, Tsuyoshi Fukuda, D Maseck, KL Curtsinger, C Liu, Kejian Zhang, TG Nick, Joseph R. Sherbotie, Eileen N. Ellis, Jens Goebel, Alexander A. Vinks> ;Clinical Pharmacology and Therapeutics. 2009 May 1
• 43 citations
  Efficacy, safety, and pharmacokinetics of candesartan cilexetil in hypertensive children aged 6 to 17 years.
  Howard Trachtman, James W. Hainer, Jennifer Sugg, Renli Teng, Jonathan M. Sorof, Jerilynn Radcliffe, Johan Vande Walle, Laszio Szabo, Tivadar Tulassay, Sándor Túri, Ev...> ;Journal of Clinical Hypertension. 2008 Oct 1
• 33 citations
  Collecting duct carcinoma arising in association with BK nephropathy post-transplantation in a pediatric patient. A case report with immunohistochemical and in situ hy...
  Lyska Emerson, Heather M. Carney, Lester J. Layfield, Joseph R. Sherbotie> ;Pediatric Transplantation. 2008 Aug 1
• 5 citations
  Clustering of post-diarrheal (Shiga toxin-mediated) hemolytic uremic syndrome in families.
  Richard L. Siegler, Joseph R. Sherbotie, N. D. Denkers, Andrew T. Pavia> ;Clinical Nephrology. 2003 Aug 1
• Modifications in cyclosporine (CsA) microemulsion blood concentrations by olestra.
  Cynthia J. Terrill, Jennifer Lill, K.Troy Somerville, Joseph R. Sherbotie> ;Journal of Renal Nutrition. 2003 Jan 1
• 1 citations
  Recurrent Hemolytic Uremic Syndrome
  Richard L. Siegler, Andrew T. Pavia, Joseph R. Sherbotie> ;Clinical Pediatrics. 2002 Nov 1
• 4 citations
  Conversion from cyclosporine to tacrolimus is preferred by pediatric renal transplant recipients: a focus on opinions and outcomes.
  A.K Sundberg, Lonnie Smith, K. T. Somerville, R Cox, Joseph R. Sherbotie> ;Transplantation Proceedings. 2002 Aug 1
• 12 citations
  Indications, results, and complications of tacrolimus conversion in pediatric renal transplantation
  Joseph T. Flynn, Timothy E. Bunchman, Joseph R. Sherbotie> ;Pediatric Transplantation. 2001 Dec 1
• 54 citations
  The use of mycophenolate mofetil suspension in pediatric renal allograft recipients.
  Timothy E. Bunchman, Mercedes Navarro, Michel Broyer, Joseph R. Sherbotie, Blanche M. Chavers, Burkhard Tönshoff, Patricia E. Birk, Gary Lerner, David S. Lirenman, Lau...> ;Pediatric Nephrology. 2001 Dec 1
• 14 citations
  Hemolytic uremic syndrome associated with Denys-Drash syndrome.
  Joseph R. Sherbotie, Veronica van Heyningen, Richard Axton, Kathy Williamson, L S Finn, Bernard S. Kaplan> ;Pediatric Nephrology. 2000 Oct 1
• Automated peritoneal dialysis using amino acid dialysate in a child with suspected hepatic steatosis.
  Joseph R. Sherbotie, Chris Breen> ;Peritoneal Dialysis International. 1998 Jan 1
• Microangiopathic hemolytic anemia, thrombocytopenia, and renal injury during continuous venovenous hemodialysis in a neonate.
  Joseph R. Sherbotie> ;Pediatric Nephrology. 1995 Dec 1
• 51 citations
  Determinants of survival in pediatric continuous hemofiltration.
  W E Smoyer, C. McAdams, Bernard S. Kaplan, Joseph R. Sherbotie> ;Journal of the American Society of Nephrology. 1995 Nov 1
• Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily.
  Shiraga, H., Min, W., VanDusen, W. J., Clayman, M. D., Miner, D., Terrell, C. H., Sherbotie, J. R., Foreman, J. W., Przysiecki, C., Neilson, E. G.> ;Proc Natl Acad Sci U S A. 1992 Jan 1
• 18 citations
  Management of urinary tract infections in children.
  Joseph R. Sherbotie, David Cornfeld> ;The Medical Clinics of North America. 1991 Mar 1
• 27 citations
  Continuous arteriovenous hemofiltration/dialysis improves pulmonary gas exchange in children with multiple organ system failure.
  Joseph V. Dicarlo, Thomas E. Dudley, Joseph R. Sherbotie, Bernard S. Kaplan, Andrew T. Costarino> ;Critical Care Medicine. 1990 Aug 1
• Join now to see all